The Lancet Psychiatry
Fecha de publicación: 7 january 2019
DOI: https://doi.org/10.1016/S2215-0366(18)30464-4
Autores: Tessa F Blanken, MSc., Jeroen S Benjamins, PhD., Prof Denny Borsboom, PhD., Prof Jeroen K Vermunt, PhD., Casey Paquola, BSc.,
Jennifer Ramautar, PhD., et al.
Background: Insomnia disorder is the second most prevalent mental disorder, and it is a primary risk factor for depression. Inconsistent clinical and biomarker findings in patients with insomnia disorder suggest that heterogeneity exists and that subtypes of this disease remain unrecognised.
